SCHEMBL21112926

SCHEMBL21112926

Cc1c(Oc2ccccc2)cccc1C(=O)OC[C@H]1O[C@@H](O)[C@H](OC(C)[Si](C)(C)C)[C@@H](O)[C@@H]1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.38
ALDH1A1 P00352 6/20 0.38
MAPT P10636 3/20 0.36
RECQL P46063 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
HTT P42858 2/20 0.35
KDM4E B2RXH2 2/20 0.34
TYMP P19971 1/20 0.34
MAPK1 P28482 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
POLB P06746 2/20 0.32
ESR1 P03372 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
APEX1 P27695 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20873306 0.81 TTR (0.44) TSHRALDH1A1MAPTSMN1; SMN2KMT2A
SCHEMBL21112928 0.76 TYMP (0.41) TSHRALDH1A1SMN1; SMN2KDM4ETYMP
SCHEMBL21112859 0.70 SRD5A2 (0.38) ALDH1A1SMN1; SMN2HTTKDM4EMEN1
SCHEMBL1656093 0.70 TSHR (0.59) TSHRALDH1A1MAPTRECQLNPSR1
SCHEMBL21112893 0.69 SMN1; SMN2 (0.45) ALDH1A1MAPTSMN1; SMN2HTTMEN1
SCHEMBL21112880 0.68 MEN1 (0.43) ALDH1A1MAPTHTTTYMPMEN1
SCHEMBL21112940 0.67 TTR (0.50) TSHRALDH1A1MAPTSMN1; SMN2MAPK1
SCHEMBL21112985 0.67 SLC5A2 (0.43) ALDH1A1SMN1; SMN2HTTKDM4ETDP1
SCHEMBL12318338 0.67 KDM4E (0.47) TSHRALDH1A1KDM4ETYMPMEN1
SCHEMBL12270093 0.67 KDM4E (0.47) TSHRALDH1A1KDM4ETYMPMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11090364-B2 Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein SANOFI (FR) 2021-08-17 US disclosed
US-20190209656-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11090364-B2 Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein GPR119, SLC2A8, SLC2A4 TSHR 552/4885ALDH1A1 1514/4885MAPT 3717/4885
US-20190209656-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 TSHR 552/4885ALDH1A1 1514/4885MAPT 3717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.